Scarica l'app Stockscreener
2.705
2.03%
0.035
Dopo l'orario di chiusura:
2.71
0.005
+0.18%
Precedente Chiudi:
$2.67
Aprire:
$2.66
Volume 24 ore:
473.20K
Relative Volume:
0.54
Capitalizzazione di mercato:
$207.54M
Reddito:
$4.72B
Utile/perdita netta:
$-123.85M
Rapporto P/E:
-0.1892
EPS:
-14.2981
Flusso di cassa netto:
$-303.12M
1 W Prestazione:
-10.38%
1M Prestazione:
-18.19%
6M Prestazione:
-82.02%
1 anno Prestazione:
-82.02%
Intervallo 1D:
$2.58
$2.755
Intervallo di 1 settimana:
$2.58
$3.175
Portata 52W:
$1.885
$4.6887
Accendra Health Inc Stock (ACH) Company Profile
Nome
Accendra Health Inc
Settore
Industria
Telefono
(804) 277-4304
Indirizzo
4435 WATERFRONT DRIVE, GLEN ALLEN
Compare ACH vs MCK, COR, CAH, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACH
Accendra Health Inc
|
2.71 | 204.48M | 4.72B | -123.85M | -303.12M | -14.30 |
MCK
Mckesson Corp
|
766.26 | 90.72B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
265.45 | 51.51B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
200.68 | 46.66B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
73.51 | 8.34B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
1.51 | 1.37B | 14.85M | -136.07M | 7.25M | -0.4726 |
Accendra Health Inc Stock (ACH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-03 | Downgrade | UBS | Buy → Neutral |
| 2024-07-19 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-12 | Downgrade | BofA Securities | Buy → Underperform |
| 2022-10-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-04-26 | Ripresa | Citigroup | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2022-03-30 | Ripresa | JP Morgan | Underweight |
| 2022-03-23 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2021-04-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-03-08 | Aggiornamento | Goldman | Sell → Buy |
| 2020-12-17 | Aggiornamento | UBS | Neutral → Buy |
| 2020-09-25 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2020-07-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-07-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-05-05 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-01-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-01-07 | Downgrade | Goldman | Neutral → Sell |
| 2019-11-15 | Aggiornamento | CLSA | Underperform → Outperform |
| 2019-09-06 | Reiterato | BofA/Merrill | Neutral |
| 2019-04-10 | Reiterato | BofA/Merrill | Neutral |
| 2019-04-03 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-04-01 | Aggiornamento | JP Morgan | Underweight → Overweight |
| 2019-01-18 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2019-01-15 | Aggiornamento | CLSA | Underperform → Outperform |
| 2018-12-14 | Downgrade | Morgan Stanley | Overweight → Underweight |
| 2018-12-12 | Downgrade | Goldman | Buy → Neutral |
| 2018-09-28 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-11 | Downgrade | CLSA | Outperform → Sell |
| 2018-04-10 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-03-26 | Aggiornamento | Goldman | Sell → Neutral |
| 2017-11-02 | Downgrade | HSBC Securities | Buy → Hold |
| 2016-03-24 | Aggiornamento | Goldman | Sell → Neutral |
| 2015-12-07 | Downgrade | Goldman | Neutral → Sell |
| 2015-08-31 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2012-08-01 | Iniziato | HSBC Securities | Underweight |
| 2009-08-05 | Aggiornamento | Citigroup | Sell → Buy |
| 2008-12-01 | Downgrade | HSBC Securities | Neutral → Underweight |
Mostra tutto
Accendra Health Inc Borsa (ACH) Ultime notizie
Accendra Health (ACH) shares jump after first-quarter earnings beat - MSN
Accendra Health (ACH) price target increased by 28.92% to 4.27 - MSN
Accendra Health, Inc. 8-K Filing Details: Company Information, Address, and Voting Results (May 14, 2026) - Minichart
Accendra Health Shareholders Approve Amended Omnibus Incentive Plan - TipRanks
ACH News | ACCENDRA HEALTH INC (NYSE:ACH) - ChartMill
Accendra Health, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:ACH) 2026-05-14 - Seeking Alpha
ACCENDRA HEALTH INCANNOUNCES OVER $1.5 BLN BALANCE SHEET OPTIMIZATION DEAL - Moomoo
Accendra Health 1Q Adj Loss/Shr 4c >ACH - Moomoo
Accendra Health Q1 2026 slides: margins surge post-split, debt cut - Investing.com India
Accendra Health Inc (ACH) Q1 2026 Earnings Call Highlights: Navi - GuruFocus
Accendra Health To Effectuate Balance Sheet Optimization Transaction in Near Term >ACH - Moomoo
Accendra Health Shares Gain on Narrowed Loss, Adjusted EPS Beat - Moomoo
Accendra Health Q1 2026 slides: margins surge post-split, debt cut By Investing.com - Investing.com South Africa
Accendra Health cuts debt by $100M, extends maturities, but slow growth keeps EBITDA outlook cautious. - Pluang
Healthcare Firm Accendra Inks Discount Debt Exchange, New Funds - Bloomberg.com
Accendra Health Makes Progress Addressing Its Debt Load (NYSE:ACH) - Seeking Alpha
Accendra Health (ACH) Q1 2026 Earnings Transcript - AOL.com
Accendra Health earnings beat by $0.06, revenue fell short of estimates - Investing.com Nigeria
Accendra Health Reports Q1 2026 Financial Results and Announces $1.5 Billion Balance Sheet Optimization Transaction - Minichart
Accendra Health 2026: Leading Home-Based Care Provider with Strong Financials, Growth Strategy, and Capital Structure Optimization - Minichart
Accendra Health 1Q 2026: Revenue $627.78M, EPS ($0.08) — 10-Q Summary - TradingView
Accendra Health (ACH) Q1 2026 loss, payor exit and major debt refi plan - Stock Titan
Earnings call transcript: Accendra Health beats EPS expectations in Q1 2026 - Investing.com UK
Accendra Health (ACH) Q1 Earnings Show Mixed Results - GuruFocus
Accendra Health (ACH) Shares Jump After First-Quarter Earnings Beat - Yahoo Finance
Accendra Health 1Q Loss/Shr 8c >ACH - Moomoo
Earnings call transcript: Accendra Health beats EPS expectations in Q1 2026 By Investing.com - Investing.com South Africa
Accendra Health reports Q1, announces $1.5B optimization - HME News
Accendra Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Accendra Health reports Q1 EPS (4c) vs. 29c last year - TipRanks
Q1 2026 Accendra Health Inc Earnings Call Transcript - GuruFocus
Accendra Health (NYSE:ACH) Beats Q1 Estimates and Unveils $1.5B Debt Restructuring - ChartMill
Accendra Health Reports Q1 Loss, Launches Balance Sheet Plan - TipRanks
Accendra Health stock soars nearly 10% on first quarter earnings beat - Investing.com Australia
Accendra Health stock soars nearly 10% on first quarter earnings beat By Investing.com - Investing.com South Africa
Accendra Health (ACH) reworks debt with $326M 9% notes, $300M revolver and exchanges - Stock Titan
Accendra Health (NYSE: ACH) unveils $1.5B balance sheet overhaul with Q1 results - Stock Titan
Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction - marketscreener.com
Owens & Minor Q1 2026 earnings preview - MSN
MSN Money - MSN
ACH Stock Price, Quote & Chart | ACCENDRA HEALTH INC (NYSE:ACH) - ChartMill
Why Accendra (ACH) business model holds up in any market (Investor Interest) 2026-05-08Community Trade Ideas - newser.com
Accendra Health Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Accendra Health Inc Azioni (ACH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Accendra Health Inc Azioni (ACH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Coliseum Capital Management, L | 10% Owner |
Aug 14 '25 |
Buy |
5.31 |
492,852 |
2,617,044 |
13,100,807 |
| Coliseum Capital Management, L | 10% Owner |
Aug 13 '25 |
Buy |
5.46 |
325,000 |
1,774,500 |
12,607,955 |
3.53%
4.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):